| Objective To investigate the rationality of using recombinant human thrombopoietin injection among inpatients in a hospital.Methods A total of 126 patients who used recombinant human thrombopoietin injection in The Second Affiliated Hospital of Bengbu Medical College from January 1, 2019 to December 31, 2019 were retrospectively selected, and the rationality was evaluated based on the aspects of indication, dosage and course of treatment.Results Among the 126 medical records, 56 cases were unreasonable.The irrational use mainly included over-indication (26 cases, 20.63%), inappropriate dosage (123 cases, 97.62%) and over-course of medication (30 cases, 23.81%).Conclusion Recombinant human thrombopoietin injection in the hospital is used unreasonably in clinical practice in the form of over-indication, inappropriate dosage, over-course of medication. Therefore, it is necessary to strengthen the training of medical personnel on rational drug use, strengthen supervision and punishment to standardize rational use of recombi-nant human thrombopoietin injection. |
